Abiopharma

🔍 Webb Matthew (Director)

Company: PROVIDENT FINANCIAL HOLDINGS INC (PROV)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 7,000 shares of Common Stock, PAR Value $0.01 at $12.09 per share (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,000.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 7,000 shares of Option to Purchase Common Stock at $12.09 per share (Derivative)
  Date: 2026-07-30 | Code: M | Expires: 2033-12-14 | Exercise: 2025-12-14 | equity_swap_involved: 0 | shares_owned_after: 17,000.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023, and vested on December 14, 2025.
• F2: Includes 7,000 remaining stock options granted on December 14, 2023 under the Provident 2022 Equity Incentive Plan, which vest on December 14, 2027. Also includes the 10,000 stock options granted on May 23, 2024 under the Provident 2022 Equity Incentive Plan, 50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028.